Seoul Economic Daily EnglishCodex · 实盘不做把握 5/10
北京时间·🕒 发布 15:06:51时区推断·⟳ 抓取 15:22:58·⚡ 决策 07-30 20:43:12 +5h20m·88.9 天前
乐天精细化学Q2营业利润同比增长611%,并拟扩建TMAC产能16%
乐天精细化学Q2收入5863亿韩元、营业利润619亿韩元,同比增38.1%和611%,半导体材料TMAC销量受益需求提升。
📄 原文Seoul Economic Daily English↗ 原文
Lotte Fine Chemical Q2 Operating Profit Jumps 611% on Specialty Growth
Lotte Fine Chemical (004000.KS) said on the 30th that its operating profit rose more than 600%, driven by factors inclu…
不做 Lotte Fine Chemical(004000.KS)
利好明确但004000.KS当日已涨6.06%,且财报日历事件未核到一致预期差,次日追多edge不足。
不做 Lotte Corp(004990.KS)
集团敞口分散且当日仅小幅反应,子公司业绩和扩产对母公司短线弹性不够。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-30 · 扩散 medium · price-in 风险 medium ↗
消息传播链
- 报道称公司同日监管文件披露Q2收入5863亿韩元、营业利润619亿韩元。
- 媒体补充TMAC产能从5.5万吨扩至6.4万吨、投资130亿韩元、2028年二季度完成。市场反应:004000.KS当日收涨6.06%,004990.KS涨1.85%。
关键理由
- 乐天精细化学Q2收入5863亿韩元、营业利润619亿韩元,同比增38.1%和611%,半导体材料TMAC销量受益需求提升。
- 公司拟投资130亿韩元将TMAC年产能从5.5万吨扩至6.4万吨,约增16%,但投产时间在2028年二季度。
- 按004000.KS收盘市值口径,单季营业利润年化对市值有弹性,但股价当日已涨6.06%,且未核到一致预期差。
主要风险
- 财报属于日历事件,若市场已在当日收盘前交易业绩,次日再追容易承受高开回落。
- TMAC扩产是2028年才落地的资本开支,不能直接等同于未来几个交易日收入增量。
反向证据
- 做多前查反向 · 来源 kb_search · 影响 weakens
内部KB未命中能量化TMAC收入占比或一致预期差的资料,削弱次日追多把握。
检索:Lotte Fine Chemical TMAC semiconductor material sales revenue capacity 55000 64000 operating profit 2026 Q2
工具调用 · 历史记录,结果未知(4 种)
- search_processed_events · 结果未知
- stock_quote · 结果未知
- kb_search · 结果未知
- normalize_ticker · 结果未知
原文全文
展开原文 · 2,433 字
Lotte Fine Chemical (004000.KS) said on the 30th that its operating profit rose more than 600%, driven by factors including a boom in the semiconductor industry, one of its key downstream sectors.
Lotte Fine Chemical reported second-quarter revenue of 586.3 billion won and operating profit of 61.9 billion won, according to a regulatory filing the same day. The figures represent increases of 38.1% and 611%, respectively, from a year earlier.
The company cited several drivers behind the improved earnings, including an overall improvement in market conditions from higher international prices of major products, and expanded sales of its specialty businesses such as food and pharmaceutical cellulose and tetramethylammonium chloride (TMAC), a semiconductor material.
Cellulose is a material used in plant-based pharmaceutical capsules and pill coatings. Growing interest in health and wellness has recently expanded the related market, and sales from an expanded plant began to increase in earnest from the second quarter. The company had previously expanded a food and pharmaceutical cellulose plant with a capacity of 6,000 tons in Incheon last year.
TMAC sales volume also increased amid rising demand in the semiconductor market, a key downstream sector. TMAC is a core raw material for tetramethylammonium hydroxide (TMAH), a developing solution used in the circuit development processes for semiconductors and displays.
On the same day, Lotte Fine Chemical said it will invest 13 billion won to expand its TMAC plant. The company plans to increase its TMAC production capacity, currently the world's largest at 55,000 tons per year, to 64,000 tons by the second quarter of 2028, an expansion of about 16%.
The company is also expanding its ammonia marine fuel supply (bunkering) business. It is strengthening its eco-friendly business areas by leveraging the infrastructure of Asia's largest ammonia terminal, located near Ulsan Port. In April, Lotte Fine Chemical became the first in the world to commercially supply green ammonia as a marine fuel. This year, the company plans to supply about 3,000 tons of fuel to ammonia-powered vessels.
"We decided on the TMAC expansion investment to proactively respond to growing semiconductor demand, and we will continue to strengthen the competitiveness of our eco-friendly business by expanding the ammonia marine fuel business," said Jung Seung-won, CEO of Lotte Fine Chemical.
Lotte Fine Chemical reported second-quarter revenue of 586.3 billion won and operating profit of 61.9 billion won, according to a regulatory filing the same day. The figures represent increases of 38.1% and 611%, respectively, from a year earlier.
The company cited several drivers behind the improved earnings, including an overall improvement in market conditions from higher international prices of major products, and expanded sales of its specialty businesses such as food and pharmaceutical cellulose and tetramethylammonium chloride (TMAC), a semiconductor material.
Cellulose is a material used in plant-based pharmaceutical capsules and pill coatings. Growing interest in health and wellness has recently expanded the related market, and sales from an expanded plant began to increase in earnest from the second quarter. The company had previously expanded a food and pharmaceutical cellulose plant with a capacity of 6,000 tons in Incheon last year.
TMAC sales volume also increased amid rising demand in the semiconductor market, a key downstream sector. TMAC is a core raw material for tetramethylammonium hydroxide (TMAH), a developing solution used in the circuit development processes for semiconductors and displays.
On the same day, Lotte Fine Chemical said it will invest 13 billion won to expand its TMAC plant. The company plans to increase its TMAC production capacity, currently the world's largest at 55,000 tons per year, to 64,000 tons by the second quarter of 2028, an expansion of about 16%.
The company is also expanding its ammonia marine fuel supply (bunkering) business. It is strengthening its eco-friendly business areas by leveraging the infrastructure of Asia's largest ammonia terminal, located near Ulsan Port. In April, Lotte Fine Chemical became the first in the world to commercially supply green ammonia as a marine fuel. This year, the company plans to supply about 3,000 tons of fuel to ammonia-powered vessels.
"We decided on the TMAC expansion investment to proactively respond to growing semiconductor demand, and we will continue to strengthen the competitiveness of our eco-friendly business by expanding the ammonia marine fuel business," said Jung Seung-won, CEO of Lotte Fine Chemical.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。